Readership
Clinical Microbiologists, Clinicians, Educators, Epidemiologists, Infectious Disease Specialists, Microbiologists, Policy Makers, Scientists, Social Scientists
Scope
Published quarterly, the Official Journal of the Association of Medical Microbiology and Infectious Disease Canada (JAMMI) aims to publish scholarly articles pertaining to infectious diseases, and particularly those affecting humans. JAMMI provides a Canadian perspective covering the depth and breadth of clinical microbiology and laboratory diagnosis, clinical care and management, and epidemiology and societal issues relating to human infectious diseases by publishing peer-reviewed, high quality papers to a broad international and multidisciplinary readership of researchers, clinicians, educators, and policy makers with an interest in the field. The gamut of papers published in JAMMI include original research articles, reviews of and commentary on cutting edge topics in infectious diseases, clinical guidelines for the diagnosis and management of human infectious diseases, including optimal use of antimicrobial therapies, AMMI Canada position statements, peer-reviewed abstracts from the annual AMMI Canada-CACMID National Conference along with clinical case reports related to the health and care of various populations of interest.
The ethno-geographic diversity of Canada offers a unique perspective to understanding the variety, emergence, and evolution of important infectious pathogens seen in northern regions of North America and the globe. The impact of global climate change places Canada in a position to see the northern migration of human infectious diseases caused by the emergence of diseases vectors directly related to climactic changes. The vast longitudinal expanse of Canada also contributes to understanding factors that can lead to differences in the incidence and prevalence of a variety of infectious agents and their vectors and reservoirs within a single country. Canada is home to a thriving and innovative research community examining some of the most challenging infectious agents from a global perspective. These include the National Microbiology Laboratory (NML), which has produced pioneering diagnostic and therapeutic interventions for the Ebola virus. The innovative work of the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) in exploring the virology of SARS-CoV-2 during the course of the COVID-19 pandemic, and the pioneering leadership of both the Canadian Center for Vaccinology at Dalhousie University and Vaccine Evaluation Center (VEC) at the University of British Columbia has shown the importance of disseminating important research and evidence to a worldwide audience.
Sponsoring Association(s)
Association of Medical Microbiology and Infection Disease Canada (AMMI Canada)